Asunercept as an Innovative Therapeutic Approach for Recurrent Glioblastoma and Other Malignancies

Cancer Management and Research - New Zealand
doi 10.2147/cmar.s216675
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Informa UK Limited

Related search

EZH2 as a Therapeutic Target for Multiple Myeloma and Other Haematological Malignancies

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2018English

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma

Clinical Medicine Insights: Oncology
Oncology
2015English

EGFR and mTOR as Therapeutic Targets in Glioblastoma

Oncotarget
Oncology
2019English

Utilizing TH9 Cells as a Novel Therapeutic Strategy for Malignancies

OncoImmunology
OncologyAllergyImmunology
2013English

Eph Receptors as Therapeutic Targets in Glioblastoma

British Journal of Cancer
Cancer ResearchOncology
2014English

A Kidney Transplant Recipient With Recurrent Trichilemmal Carcinoma and Multiple Other Primary Malignancies

African Journal of Nephrology
2020English

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study

OncoTargets and Therapy
OncologyPharmacology
2019English

Autologous T-Cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

Cancer Research
Cancer ResearchOncology
2014English

An Innovative Approach for E-Government Transformation

International Journal of Managing Value and Supply Chains
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy